United States Change Country
Careers | Investor Relations | News & Media | Events | About KCI |
KCI EXPRESS ORDER NOW Customer Support
CALL 1-800-275-4524
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support
You are here: Home > Products > V.A.C. Therapy > V.A.C. Therapy Economic Value
Print

V.A.C. Therapy Economic Value

Effective wound management is vital to positive patient outcomes, reduced healthcare expenditures and effective resource utilization. Clinically proven wound closure using V.A.C.® Therapy not only helps improve patient outcomes, it can help facilities and payors lower their overall cost of care.

The V.A.C. Therapy body of evidence is one of the most substantial in the wound care industry . Studies have shown that V.A.C. Therapy can cost significantly less than standard treatment modalities for a wide range of acute, chronic and traumatic wounds across all care settings when looking at overall cost of care, the true indicator of healthcare savings.

As with all study related data, outcomes for specific patients or at an individual institution may vary; however, based on clinical outcomes reported in randomized controlled trials and nonrandomized comparative studies, the use of V.A.C. Therapy has been associated with the following positive effects in patients studied:


Wound Healing with Demonstrated Cost Effectiveness

Please click below for information about specific studies and outcomes.
Reduced length of stay 1-5     
Reduced overall medical costs 1,2,3,6,7  
Reduced hospital staff time 3,6,8,9  
Reduced need for outpatient visits 8  
Reduced need for emergency care or readmission 10,11  
Lower incidence of amputations in patients with diabetic foot ulcers, based on a 1-2 year review of payer claims data 14
Reduced risk for other surgical procedures in open foot wounds for patients observed during a 2-year period 11,15,16  


Recent Randomized Controlled Trials for Diabetic Foot Ulcers & Amputations:

Please click below for information about specific studies and outcomes.
Reduced relative risk of secondary amputations in patients with diabetic foot and partial diabetic foot amputation wounds at the end of a 4-month active treatment phase 12,13  
Higher number of patients achieving complete wound closure at the end of a 4-month active treatment phase 12,13
Lower cost of care due to fewer surgical procedures, dressing changes and outpatient visits 8
 

Reported V.A.C. Therapy Savings

Chronic Wounds Savings
Pressure ulcers $8,919
Diabetic foot ulcers (in Home Health) $11,958
Diabetic foot amputations $9,915

 

Traumatic Wounds Savings
Open abdomen management $31,000
Orthopedic trauma split thickness skin grafts $950

For additional information, or to speak with a member of the KCI Health Economics team, please send an email to HealthEconomics@kci1.com
 

You can also  view titles of published data that demonstrates the positive clinical and financial outcomes associated with V.A.C. Therapy.
 

 

Print
Bookmark this page. del.icio.us